S.755

Finn Sawyer Access to Cancer Testing Act amends Medicare, Medicaid, and CHIP to cover cancer diagnostic and laboratory tests.

The Finn Sawyer Access to Cancer Testing Act amends Medicare, Medicaid, and the Children's Health Insurance Program (CHIP) to cover cancer diagnostic and laboratory tests. It also mandates an education and awareness program for physicians and the public on genomic testing. Effective January 1, 2027, Medicare will cover these tests, and Medicaid and CHIP will include them in their coverage starting January 1, 2025.